Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VAB-7 vs VA-14 for First-Line Eradication of Helicobacter Pylori
NCT07232095Phase 4Recruiting
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Jan 2026
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bismuth subsalicylate in Helicobacter pylori infection, sponsored by Jiangsu Provincial People's Hospital. Started Jan 2026; status: recruiting.
02
Drugs
bismuth subsalicylate
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT07232095.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07232095.